TASIGNA On Demand Patient Support

Now that you’re starting on TASIGNA® (nilotinib) capsules, you can sign up for TASIGNA On Demand—a patient support program designed to help you manage Philadelphia chromosome–positive chronic myeloid leukemia in chronic phase (Ph+ CML-CP). 

 

Get the support of TASIGNA On Demand 

The TASIGNA On Demand patient support program provides helpful information via mail and email, including: 

  • Educational materials about Ph+ CML and TASIGNA
  • Information about the importance of going for blood tests—and understanding what your results mean
  • Background on treatment milestones to discuss with your doctor
  • Tips to help you manage Ph+ CML
  • Information about saving on TASIGNA

Demand


 

To sign up, complete the information below. Be sure to hit the “Submit” button at the bottom of this page.

 

Sign up for patient support from TASIGNA On Demand 

To sign up for TASIGNA On Demand, please fill out the information below and then click the “Submit” button. You must be 18 years of age or older to enroll.

  1. 1/1:Enter Your Information

* Required Field

Are you or a loved one currently taking TASIGNA? *

Did you receive a TASIGNA Patient Starter Kit from your doctor?*

**Treatment-free remission is the possibility for eligible adult patients with Ph+ CML-CP to come off treatment. 

  • Your health care provider will monitor your Ph+ CML during treatment with TASIGNA to see if you are in a remission. After at least 3 years of treatment with TASIGNA, your health care provider may do certain tests to determine if you continue to be in remission. Based on your test results, your health care provider may decide if you may be eligible to try stopping treatment with TASIGNA. This is called TFR
  • Your health care provider will carefully monitor your Ph+ CML-CP during and after you stop taking TASIGNA. If your tests results show your Ph+ CML-CP is no longer in remission, your doctor will restart TASIGNA treatment
  • It is important for your health care provider to perform frequent monitoring to find out if you need to restart your TASIGNA treatment because you are no longer in TFR. Follow your health care provider’s instructions about restarting TASIGNA if you are no longer in TFR

 

Privacy Notice

By clicking "Submit," I agree to the Novartis Pharmaceuticals Corporation Terms of Use. I understand and agree that the information I provide will be used in accordance with the Novartis Privacy Policy, including to provide me with marketing information, offers, and promotions and to contact me for my opinions regarding products, programs, and services. I understand that unless I unsubscribe, by calling 1-800-282-7630 or clicking unsubscribe in a promotional e-mail, my consent will remain valid. I also understand that I may receive nonmarketing calls and texts from and on behalf of Novartis about TASIGNA, including through an autodialer or prerecorded voice, at the telephone number(s) I have provided. 

Please complete all required fields.